Keyphrases
Adrenoleukodystrophy
100%
X-linked
37%
Marrow
33%
Neurofilament Light (NF-L)
33%
Novel Biomarkers
33%
Non-collagenous Proteins
33%
Dermatopontin
33%
Hematopoietic Cells
33%
GPNMB
33%
Imaging Biomarkers
33%
Leukodystrophy
33%
Blood-brain Barrier Disruption
33%
Bevacizumab
33%
Cerebrospinal Fluid
29%
Cortisol
16%
Vascular Permeability
16%
Enhanced Permeability
16%
Adrenal Insufficiency
16%
Late Gadolinium Enhancement
16%
Immune Suppressants
16%
Clinical Manifestations
16%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
16%
Permeability Increase
16%
Ruxolitinib
16%
Anisotropy
16%
Endothelial Cell Line
16%
VEGF Secretion
16%
Endothelial Function
16%
Young Males
14%
Hematopoietic Stem Cells
13%
Transendothelial Migration
13%
Hematopoietic Cell Transplant
13%
Zebrafish
13%
Cell Homing
13%
Extracellular Matrix
13%
Niche Cells
13%
Plasma Neurofilament Light Chain
11%
Potential Biomarkers
7%
Disease Progression
7%
Cell Engraftment
6%
Co-incubation
6%
C-kit
6%
Long-term Engraftment
6%
Transplantation Conditioning
6%
VLA-4
6%
Endothelial Cell Adhesion
6%
Expression Analysis
6%
Recombinant
6%
Lipopolysaccharide
6%
Knock-in Mouse Model
6%
Medicine and Dentistry
Adrenoleukodystrophy
46%
Neurodegeneration
33%
Mediator
33%
Light Chain
33%
Neurofilament
33%
Biological Marker
33%
Vasculotropin
33%
Leukodystrophy
33%
Blood Brain Barrier
33%
Hematopoietic Cell
33%
Corticotropin
20%
Bevacizumab
13%
Cerebrospinal Fluid
11%
Transplantation
7%
Cell Homing
7%
Engraftment
7%
Conditioning
7%
Immunosuppressive Drug
6%
Endothelial Cell Line
6%
Hydrocortisone
6%
Dexamethasone
6%
Adrenal Insufficiency
6%
Magnetic Resonance Imaging
6%
Endothelial Function
6%
Ruxolitinib
6%
Secretion (Process)
6%
Gadolinium
6%
Biochemistry, Genetics and Molecular Biology
Adrenoleukodystrophy
66%
Mediator
33%
Glycoprotein
33%
Light Chain
33%
Hematopoietic Cell
33%
Neurofilament Light
33%
Liquid
29%
Blood Plasma
14%
Cell Homing
7%
Zebra Fish
7%
Conditioning
7%
ABCD1
7%
